These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody. Jenkins EA; Hull RG; Thomas AL Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325 [TBL] [Abstract][Full Text] [Related]
27. Polymyositis due to D-penicillamine in a patient with systemic sclerosis. Santos JC; Velasco JA Clin Exp Dermatol; 1991 Jan; 16(1):76. PubMed ID: 2025947 [No Abstract] [Full Text] [Related]
29. [D-penicillamine-induced pemphigus, polymyositis and myasthenia]. Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832 [TBL] [Abstract][Full Text] [Related]
30. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis. Nishikai M; Funatsu Y; Homma M Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253 [No Abstract] [Full Text] [Related]
31. [Ultrastructural study of a polymyositis caused by D-penicillamine (author's transl)]. Marty-Double C; Pagès M; Pagès AM; Pellissier J; Brousson A Arch Anat Cytol Pathol; 1980; 28(6):325-8. PubMed ID: 7458422 [No Abstract] [Full Text] [Related]
32. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature. Halla JT; Fallahi S; Koopman WJ Am J Med; 1984 Oct; 77(4):719-22. PubMed ID: 6592972 [TBL] [Abstract][Full Text] [Related]
33. [Association of polymyositis and rheumatoid arthritis. Apropos of a new case not related to drug ingestion]. Jardin H; Cailleux N; Marie I; Lévesque H; Courtois H Rev Med Interne; 1996; 17(4):321-4. PubMed ID: 8761796 [TBL] [Abstract][Full Text] [Related]
34. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis. Trice JM; Pinals RS; Plitman GI Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487 [TBL] [Abstract][Full Text] [Related]
35. Penicillamine-induced pseudo-pseudoxanthoma elasticum in a patient with rheumatoid arthritis. Burge S; Ryan T Clin Exp Dermatol; 1988 Jul; 13(4):255-8. PubMed ID: 3246093 [No Abstract] [Full Text] [Related]
36. Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis. Rosenbaum J; Katz WA; Schumacher HR Ann Rheum Dis; 1980 Apr; 39(2):152-4. PubMed ID: 7387219 [TBL] [Abstract][Full Text] [Related]
37. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group. J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797 [TBL] [Abstract][Full Text] [Related]
38. Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamine. Thomas D; Gallus AS; Brooks PM; Tampi R; Geddes R; Hill W Ann Rheum Dis; 1984 Jun; 43(3):402-6. PubMed ID: 6742902 [TBL] [Abstract][Full Text] [Related]
39. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine. Williams AJ; Fordham JN; Barnes CG; Goodwin FJ Ann Rheum Dis; 1986 Jan; 45(1):82-4. PubMed ID: 3954462 [TBL] [Abstract][Full Text] [Related]